Viscofan, S.A.

As of June 30, 2026, Viscofan, S.A. carries a market capitalization of 2.66B, placing it among publicly traded companies globally. Its enterprise value stands at 2.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Viscofan, S.A.'s next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Viscofan, S.A. has 45.60M shares outstanding.

As of June 30, 2026, Viscofan, S.A. trades at a trailing price-to-earnings ratio of 16.58. The price-to-sales ratio is 2.12, and the price-to-book ratio stands at 2.92.

As of June 30, 2026, Viscofan, S.A. trades at an EV/EBITDA multiple of 10.44 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.35 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 14.92 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.95B versus a market cap of 2.66B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Viscofan, S.A. maintains a current ratio of 1.84, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 37.21, indicating elevated leverage, while an interest coverage ratio of 25.50 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Viscofan, S.A. posted a return on equity (ROE) of 17.41, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 14.08 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.82, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 14.09, useful for judging operating efficiency across full business cycles. The company generates approximately 217,685.87 in revenue per employee across its workforce of 5,771.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.95 indicates how many times Viscofan, S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Viscofan, S.A. recorded 21.60M in income tax expense. That works out to an effective tax rate of 11.91, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 181.35M, leaving 161.02M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Viscofan, S.A.'s stock has gained approximately 0.93% over the past 52 weeks. The 50-day moving average sits at 55.12, while the 200-day moving average is 57.20.

Over the twelve months ended June 30, 2026, Viscofan, S.A. generated 1.26B in revenue and converted that into 161.02M in net income, yielding earnings per share of 3.49. EBITDA reached 282.58M, while operating income came in at 197.03M.

As of June 30, 2026, Viscofan, S.A. holds 58.79M in cash and equivalents against 341.04M in total debt, resulting in a net debt position of 283.31M. Total book value stands at 911.32M, with working capital of 394.98M providing operational flexibility.

Over the twelve months ended June 30, 2026, Viscofan, S.A. posted a gross margin of 68.03, reflecting its pricing power and cost economics. The operating margin of 15.68 and net profit margin of 12.82 provide insight into operational efficiency.

Viscofan, S.A.'s most recent stock split took place on March 15, 1999 with a 1:2 split ratio.

As of June 30, 2026, Viscofan, S.A. has an Altman Z-Score of 4.28, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.